AU2908189A - Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases - Google Patents

Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases

Info

Publication number
AU2908189A
AU2908189A AU29081/89A AU2908189A AU2908189A AU 2908189 A AU2908189 A AU 2908189A AU 29081/89 A AU29081/89 A AU 29081/89A AU 2908189 A AU2908189 A AU 2908189A AU 2908189 A AU2908189 A AU 2908189A
Authority
AU
Australia
Prior art keywords
treatment
acetic acid
viral diseases
prevention
mineral salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU29081/89A
Other versions
AU612228B2 (en
Inventor
Alix-Roland Commin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2908189A publication Critical patent/AU2908189A/en
Application granted granted Critical
Publication of AU612228B2 publication Critical patent/AU612228B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A novel medicament consists of an aqueous solution containing 15 to 20 g/l of a mixture of salts formed from the sodium, magnesium, calcium, potassium, strontium and boron cations and the chloride, sulphate, carbonate and bicarbonate anions, as well as 3 to 4 % of acetic acid. Application of the preparation to the treatment of viral diseases.
AU29081/89A 1988-01-08 1988-12-21 Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases Ceased AU612228B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8800119A FR2625679B1 (en) 1988-01-08 1988-01-08 AQUEOUS PREPARATION BASED ON MINERAL SALTS AND ACETIC ACID FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES
FR8800119 1988-01-08

Publications (2)

Publication Number Publication Date
AU2908189A true AU2908189A (en) 1989-08-01
AU612228B2 AU612228B2 (en) 1991-07-04

Family

ID=9362116

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29081/89A Ceased AU612228B2 (en) 1988-01-08 1988-12-21 Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases

Country Status (11)

Country Link
EP (1) EP0347448B1 (en)
JP (1) JPH02502913A (en)
AT (1) ATE76298T1 (en)
AU (1) AU612228B2 (en)
DE (1) DE3871384D1 (en)
FR (1) FR2625679B1 (en)
LV (1) LV5660A3 (en)
OA (1) OA09160A (en)
RU (1) RU1809765C (en)
UA (1) UA13377A (en)
WO (1) WO1989006133A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627309B2 (en) * 1989-05-26 1992-08-20 Terumo Kabushiki Kaisha Preparation for blood dialysis and method for production thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0401445B1 (en) * 1989-05-31 1991-12-18 Alix-Roland Commin Aqueous preparation based on inorganic salts and acetic acid for the prevention and treatment of viral diseases
ATE233563T1 (en) * 1993-11-22 2003-03-15 Bio Life Internat Ag PREPARATION FOR THE TREATMENT OF ACNE, SEBORRHOIC DERMATITIS AND OTHER SKIN DISEASES
DE4441483C1 (en) * 1994-11-22 1996-04-04 Gsf Forschungszentrum Umwelt Use of bio-assimilated boron cpds.
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
US6048553A (en) * 1997-03-17 2000-04-11 Macquarie Veterinary Supplies Pty Ltd Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases
AU772096B2 (en) * 2000-03-14 2004-04-08 Sumika Enviro-Science Co., Ltd. Method for denaturing allergens
GB0515112D0 (en) * 2005-07-25 2005-08-31 Remedy Res Ltd Compositions for treating psychiatric conditions
FR2926465B1 (en) * 2008-01-17 2016-08-12 Alix Roland Commin ANTI-VIRAL COMPOSITION, IN PARTICULAR AIDS
EP2456452A1 (en) * 2009-07-22 2012-05-30 Alix Roland Commin Antiviral and retroviral composition, in particular for treating aids
DE102016117947A1 (en) * 2016-09-23 2018-03-29 Quality Pure Co., Ltd. With magnesium highly concentrated liquid and system, for mixing drinking water with a high concentration of magnesium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3676553A (en) * 1969-12-15 1972-07-11 Cybersol Therapeutic composition
FR2108935A1 (en) * 1970-10-21 1972-05-26 Destal Guyonnaud Michele Sterile,diluted seawater - specific isotonic solns for treating haemorrhage,shock,diarrhoea in man and animals

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627309B2 (en) * 1989-05-26 1992-08-20 Terumo Kabushiki Kaisha Preparation for blood dialysis and method for production thereof

Also Published As

Publication number Publication date
FR2625679B1 (en) 1990-02-09
JPH02502913A (en) 1990-09-13
WO1989006133A1 (en) 1989-07-13
AU612228B2 (en) 1991-07-04
LV5660A3 (en) 1994-10-20
ATE76298T1 (en) 1992-06-15
FR2625679A1 (en) 1989-07-13
EP0347448A1 (en) 1989-12-27
RU1809765C (en) 1993-04-15
DE3871384D1 (en) 1992-06-25
OA09160A (en) 1992-03-31
UA13377A (en) 1997-02-28
EP0347448B1 (en) 1992-05-20

Similar Documents

Publication Publication Date Title
HU895858D0 (en) Process for production of bubbling medical compositions containing ibupuphen
IL76119A0 (en) Initiating reperfusion treatment when heart attack symptoms are present
AU3981089A (en) Salt product and method for its preparation
AU2908189A (en) Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases
MY101750A (en) Improvements in or relating to calcium salts.
PT86400A (en) Process for preparing aqueous solutions containing a mixture of hysozyme hydrochloride and dipotassium glycyrrhizate
EP0959068A3 (en) Process for the preparation of aqueous sodium methioninate solutions and use of these solutions for the preparation of a granulate
MY109531A (en) Effervescent antacid
AU550068B2 (en) Zinc insulin stabilized with calcium or magnesium salts
FI942815A (en) Process for the preparation of high-opacity precipitated calcium carbonate by reacting sodium carbonate with calcium hydroxide
AU5639090A (en) Process for the preparation of purified calcium sulphate dihydrate by aqueous means
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
EP0150505A3 (en) 3-indolecarboxamide compounds
AU621463B2 (en) Method for the preparation of carbonic acid salts of alkali metals
EP0444000A3 (en) Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
KR880009975A (en) compound
ES8501763A1 (en) Novel derivative of thienopyridinone, its preparation and its therapeutic use.
CS884386A2 (en) Zpusob vyroby novych soli aryloxypropanolaminu s kyselinou difenyloctovou
AU570446B2 (en) Dipyridamole controlled release compositon
DE3362246D1 (en) Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle
NZ194947A (en) Composition containing calcium and ferrous ions for treatment of rheumatoid arthritis
ES2052040T3 (en) AQUEOUS PREPARATION BASED ON MINERAL SALTS AND ACETIC ACID FOR THE PREVENTION AND TREATMENT OF VIRAL DISEASES.
PT90096A (en) PROCESS FOR THE PREPARATION OF ORAL ADMINISTRABLE PHARMACEUTICAL COMPOSITIONS FOR THE REPLACEMENT THERAPY OF IRON AND MAGNESIUM CONTAINING COMPOUNDS THAT ORIGINATE IONS CHLORIDE IN AQUEOUS MEDIUM
ES8702304A1 (en) Process for the manufacture of dense anhydrous sodium carbonate, and dense anhydrous sodium carbonate obtained by this process.
GR3001567T3 (en) Process for the preparation of beta-hydroxybutyric acid and its salts by means of hydrolysis of oligomers of beta-hydroxybutyric acid in a basic medium